Frontlight ResearchEarly access
Trial site
The First Peoples Hospital of Changzhou
- 5running trials
- 5closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia3 trials
- Gastric and oesophageal cancer2 trials
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Heart failure1 trial
- Myeloproliferative neoplasms1 trial
- Obesity1 trial
- Osteoporosis1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Terminated3 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- BeiGene3 trials
- BeOne Medicines3 trials
- Amgen2 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Incyte Corporation1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure1 recruiting
- Obesity1 recruiting
Closed trials
Terminated
Completed
Terminated
A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
Terminated
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026